Page 6 - Clinical Trial Registry News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Clinical trial registry. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Clinical Trial Registry Today - Breaking & Trending Today

Neem formulation 55% effective in preventing Covid, says Nisarga Biotech


Neem formulation 55% effective in preventing Covid, says Nisarga Biotech
May 20, 2021
 
Nisarga Biotech Pvt Ltd, which offers 40 natural therapeutic products for chronic diseases, recently launched Nisarga Neem Capsules that has proven to be an effective preventive remedy for Covid-19 after its recently concluded clinical trials in April 2021.
BusinessLine caught up with the Satara, Maharashtra headquartered company’s founder and CEO Girish Soman, to find out more. Excerpts:
What led to the creation of Nisarga’s neem capsules as a prophylactic for Covid-19?
Nisarga’s clinical trial was based on its patent-pending neem leaf extract, well researched for six years in pre-clinical studies with a reputed research institute in the US and toxicity studies completed as per the USFDA norms. Neem has been reported to exert anti-inflammatory, antibacterial/antiviral and antioxidant effects in our research as well as previously conducted anti-docking studies ma ....

United States , New Delhi , Journal Of Alternative Therapies In Health , Nisarga Biotech Pvt Ltd , India Institute Of Ayurveda , Nisarga Neem Capsules , All India Institute , Alternative Therapies , Clinical Trial Registry , Nisarga Biotech , Girish Soman , ஒன்றுபட்டது மாநிலங்களில் , புதியது டெல்ஹி , இந்தியா நிறுவனம் ஆஃப் ஆயுர்வேதம் , அனைத்தும் இந்தியா நிறுவனம் , மாற்று சிகிச்சைகள் , மருத்துவ சோதனை பதிவு , கிரீஷ் சோமன் ,

India's Drug Regulator Has Approved DRDO's New COVID Drug on Missing Evidence


Healthcare workers transfer the body of a person who died from COVID-19, at a hospital in Kolkata, May 12, 2021. Photo: Reuters/Rupak De Chowdhuri
Mumbai: On May 1, the Drug Controller General of India (DCGI) approved a drug called 2-deoxy-d-glucose (2-DG) for emergency use among people with moderate and severe COVID-19, to help manage the disease.
This drug was jointly developed by researchers at the Institute of Nuclear Medicine and Allied Sciences, which falls under the Defence Research & Development Organisation (DRDO), and the pharmaceutical giant Dr Reddy’s Laboratories.
In line with the DCGI’s approval for favipiravir, itolizumab and Verafin, the approval for 2-DG is based on poor evidence. ....

West Bengal , Andhra Pradesh , Drug Administration , Indian Council Of Medical Research , Ministry Of Defence , Centre For Cellular , Ministry Of Defence Press Information Bureau , Mahatma Gandhi Institute Of Medical Sciences , Institute Of Nuclear Medicine , Patanjali Research Institute , Defence Research Development Organisation , Drug Controller General , Nuclear Medicine , Allied Sciences , Defence Research , Development Organisation , Wire Science , Molecular Biology , Press Information , Clinical Trial Registry , Indian Council , Medical Research , Mahatma Gandhi Institute , Medical Sciences , Priyanka Pulla , மேற்கு பெங்கல் ,

Efficacy of live attenuated and inactivated influenza vaccines among children in rural India: A 2-year, randomized, triple-blind, placebo-controlled trial


Research Article
Efficacy of live attenuated and inactivated influenza vaccines among children in rural India: A 2-year, randomized, triple-blind, placebo-controlled trial
Anand Krishnan ,
Roles
Conceptualization,
Formal analysis,
Funding acquisition,
Methodology,
Project administration,
Resources,
Supervision,
Writing – original draft,
Writing – review & editing
Affiliation
Microbiology Department, All India Institute of Medical Sciences, Delhi, India

Siddhartha Saha,
Roles
Conceptualization,
Formal analysis,
Funding acquisition,
Methodology,
Project administration,
Resources,
Supervision,
Writing – original draft,
Writing – review & editing
Affiliation
Influenza Program, Centers for Disease Control and Prevention, New Delhi, India
Affiliation
Influenza ....

United States , United Kingdom , New Delhi , Sanofi Pasteur , A Hong Kong , Institutional Ethics Committee , Centers For Disease , National Institute Of Virology , While The World Health Organization , Us Centers For Disease , World Health Organization , Advisory Committee On Immunization Practices , University Of Sheffield , India Institute Of Medical Sciences , Serum Institute Of India Pune , Trials Registry , Thushan De Silva , Creative Commons , Mendeley Data , Disease Control , Advisory Committee , Immunization Practices , All India Institute , Medical Sciences , Drug Controller General , National Institute ,